By activating the NF-κB and Erk1/2 signaling pathways, these EBV-miR-BART8-3p (micro-RNAs) directly target RNT38 in NPC cells, enhancing the progression of NPC by inducing NPC cell migration, invasion, metastasis, epithelial–mesenchymal transition, and expression of NPC metastatic proteins [41]. This evidence concerns the gene MAPK3 and nasopharyngeal carcinoma.